Skip to main content
Premium Trial:

Request an Annual Quote

OraSure Technologies: Scott Gleason

OraSure Technologies has appointed Scott Gleason as senior vice president of investor relations and corporate communications. Gleason previously served as SVP of investor relations and corporate strategy for Myriad Genetics. Prior to that, he was a senior publishing analyst at Stephens from 2005 to 2013, covering the life science tools and diagnostics industry. Gleason also was a US Air Force aircraft maintenance officer and participated in two wartime deployments.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.